Teva- Pharmaceutical Industries Ltd. - ADR

TEVA

Market Cap$18.27B

Close$

Compare Teva- Pharmaceutical Industries Ltd.

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Teva- Pharmaceutical Industries Ltd. - ADR	-37.1	0%	-7%	1.2	2.7
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$17.67

Target Price by Analysts

8.5% upsideTeva- Pharmaceutical Industries Ltd. Target Price Details

$-4.43

Current Fair Value

127.2% downside

Overvalued by 127.2% based on the discounted cash flow analysis.

Share Statistics

Market cap	$18.27 Billion
Enterprise Value	$34.93 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.44
Beta	0.5
Outstanding Shares	1,120,992,397
Avg 30 Day Volume	12,442,553

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-37.14
PEG	115.35
Price to Sales	1.16
Price to Book Ratio	2.72
Enterprise Value to Revenue	2.18
Enterprise Value to EBIT	10.49
Enterprise Value to Net Income	-71
Total Debt to Enterprise	0.56
Debt to Equity	2.7

Revenue Sources

No data

ESG Score

No data

About Teva- Pharmaceutical Industries Ltd.

CEO: Kaare Schultz